Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?

Gridelli, Cesare

doi: 10.1097/CCO.0b013e328341ee26
Lung and mediastinum: Edited by Cesare Gridelli
Buy

Division of Medical Oncology, ‘S.G. Moscati’ Hospital, Avellino, Italy

Correspondence to Cesare Gridelli, MD, Division of Medical Oncology, ‘S.G. Moscati’ Hospital, Città Ospedaliera 8, Contrada Amoretta, 83100 Avellino, Italy Tel: +39 0825 203573; fax: +39 0825 203556; e-mail: cgridelli@libero.it website www.gridelli.it

© 2011 Lippincott Williams & Wilkins, Inc.